| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.038 | 0.8 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.041 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |